Poor potential coverage for 7-valent pneumococcal conjugate vaccine, Malawi

Stephen Gordon; Stonard Kanyanda; Amanda L. Walsh; Kirsty Goddard; Mas Chaponda; Victoria Atkinson; Wakisa Mulwafu; Elizabeth M. Molyneux; Ed E. Zijlstra; Malcolm E. Molyneux; Steve M. Graham

doi:10.3201/eid0906.030020

Poor potential coverage for 7-valent pneumococcal conjugate vaccine, Malawi

Stephen Gordon, Stonard Kanyanda, Amanda L. Walsh, Kirsty Goddard, Mas Chaponda, Victoria Atkinson, Wakisa Mulwafu, Elizabeth M. Molyneux, Ed E. Zijlstra, Malcolm E. Molyneux, Steve M. Graham

Research output: Contribution to journal › Article › peer-review

43 Citations (Scopus)

Abstract

Streptococcus pneumoniae infections can be prevented by using new conjugate vaccines, but these vaccines have limited serogroup coverage. We report the first serogrouping data from carried and invasive isolates obtained from children and adults in Malawi. The 7-valent vaccine would cover 41% of invasive isolates from children and 25% from adults. A 9-valent vaccine, including types 1 and 5, would cover 66% of invasive isolates from children and 55% from adults.

Original language	English
Pages (from-to)	747-749
Number of pages	3
Journal	Emerging Infectious Diseases
Volume	9
Issue number	6
DOIs	https://doi.org/10.3201/eid0906.030020
Publication status	Published - 1 Jun 2003
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3201/eid0906.030020

Cite this

@article{3d1f8382ab7543e7adf820a44cea53f9,

title = "Poor potential coverage for 7-valent pneumococcal conjugate vaccine, Malawi",

abstract = "Streptococcus pneumoniae infections can be prevented by using new conjugate vaccines, but these vaccines have limited serogroup coverage. We report the first serogrouping data from carried and invasive isolates obtained from children and adults in Malawi. The 7-valent vaccine would cover 41\% of invasive isolates from children and 25\% from adults. A 9-valent vaccine, including types 1 and 5, would cover 66\% of invasive isolates from children and 55\% from adults.",

author = "Stephen Gordon and Stonard Kanyanda and Walsh, \{Amanda L.\} and Kirsty Goddard and Mas Chaponda and Victoria Atkinson and Wakisa Mulwafu and Molyneux, \{Elizabeth M.\} and Zijlstra, \{Ed E.\} and Molyneux, \{Malcolm E.\} and Graham, \{Steve M.\}",

year = "2003",

month = jun,

day = "1",

doi = "10.3201/eid0906.030020",

language = "English",

volume = "9",

pages = "747--749",

journal = "Emerging Infectious Diseases",

issn = "1080-6040",

publisher = "Centers for Disease Control and Prevention (CDC)",

number = "6",

}

TY - JOUR

T1 - Poor potential coverage for 7-valent pneumococcal conjugate vaccine, Malawi

AU - Gordon, Stephen

AU - Kanyanda, Stonard

AU - Walsh, Amanda L.

AU - Goddard, Kirsty

AU - Chaponda, Mas

AU - Atkinson, Victoria

AU - Mulwafu, Wakisa

AU - Molyneux, Elizabeth M.

AU - Zijlstra, Ed E.

AU - Molyneux, Malcolm E.

AU - Graham, Steve M.

PY - 2003/6/1

Y1 - 2003/6/1

N2 - Streptococcus pneumoniae infections can be prevented by using new conjugate vaccines, but these vaccines have limited serogroup coverage. We report the first serogrouping data from carried and invasive isolates obtained from children and adults in Malawi. The 7-valent vaccine would cover 41% of invasive isolates from children and 25% from adults. A 9-valent vaccine, including types 1 and 5, would cover 66% of invasive isolates from children and 55% from adults.

AB - Streptococcus pneumoniae infections can be prevented by using new conjugate vaccines, but these vaccines have limited serogroup coverage. We report the first serogrouping data from carried and invasive isolates obtained from children and adults in Malawi. The 7-valent vaccine would cover 41% of invasive isolates from children and 25% from adults. A 9-valent vaccine, including types 1 and 5, would cover 66% of invasive isolates from children and 55% from adults.

U2 - 10.3201/eid0906.030020

DO - 10.3201/eid0906.030020

M3 - Article

SN - 1080-6040

VL - 9

SP - 747

EP - 749

JO - Emerging Infectious Diseases

JF - Emerging Infectious Diseases

IS - 6

ER -

Poor potential coverage for 7-valent pneumococcal conjugate vaccine, Malawi

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this